🇺🇸 FDA
Pipeline program

UVEDOSE 100 000 UI, solution buvable en ampoule

CHRD2115

Phase 3 small_molecule active

Quick answer

UVEDOSE 100 000 UI, solution buvable en ampoule for Thyroidectomy is a common operation. Transient postoperative hypocalcemia is the main complication, resulting in clinical discomfort for patients, longer hospital stays and increased perioperative cost. Cholecalciferol is used to supplement vitamin D deficiency. We suppose that systematic pre-operative supplementation with cholecalciferol would allow a faster and more appropriate response to post-operative hypocalcemia is a Phase 3 program (small_molecule) at Novo mesto with 1 ClinicalTrials.gov record(s).

Program details

Company
Novo mesto
Indication
Thyroidectomy is a common operation. Transient postoperative hypocalcemia is the main complication, resulting in clinical discomfort for patients, longer hospital stays and increased perioperative cost. Cholecalciferol is used to supplement vitamin D deficiency. We suppose that systematic pre-operative supplementation with cholecalciferol would allow a faster and more appropriate response to post-operative hypocalcemia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials